Accounting for the placebo response in cost-effectiveness analysis

被引：0

|

作者：

McDonald, H. P. ^{[1
]}

Rebeira, M. ^{[1
]}

Wright, S. ^{[2
]}

Jaszewski, B. ^{[1
]}

机构：

[1] Bayer Inc, Toronto, ON, Canada

[2] GW Pharma Ltd, Salisbury, Wilts, England

来源：

VALUE IN HEALTH | 2008年 / 11卷 / 03期

关键词：

D O I：

10.1016/S1098-3015(10)70546-5

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

收藏

页码：A172 / A172

页数：1

相关论文

共 50 条

[41] Cost-effectiveness analysis of paclitaxel
Eandi, Mario
FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2006, 7 (02) : 97 - 117
[42] COST-EFFECTIVENESS OF GENTAMICIN AND TOBRAMYCIN - IN RESPONSE
HOLLOWAY, JJ
SMITH, CR
MOORE, RD
LIETMAN, PS
ANNALS OF INTERNAL MEDICINE, 1985, 102 (06) : 867 - 868
[43] Is cost-effectiveness analysis unfair?
Russell, LB
MEDICAL DECISION MAKING, 2004, 24 (02) : 232 - 234
[44] Cost-effectiveness analysis - Reply
Hueston, WJ
JOURNAL OF FAMILY PRACTICE, 1997, 44 (06): : 524 - 525
[45] Cost-effectiveness analysis and innovation
Jena, Anupam B.
Philipson, Tomas J.
JOURNAL OF HEALTH ECONOMICS, 2008, 27 (05) : 1224 - 1236
[46] Cost-effectiveness analysis of telemedicine
Crowe, BL
JOURNAL OF TELEMEDICINE AND TELECARE, 1998, 4 : 14 - 17
[47] COST-EFFECTIVENESS ANALYSIS - WILL IT BE ACCEPTED
EDDY, DM
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (01): : 132 - 136
[48] Visualizing cost-effectiveness analysis
Mark, DH
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (18): : 2428 - 2429
[49] Modelling for cost-effectiveness analysis
Russell, LB
STATISTICS IN MEDICINE, 1999, 18 (23) : 3235 - 3244
[50] A Primer on Cost-Effectiveness Analysis
Albright, Rachel H.
Fleischer, Adam E.
JOURNAL OF HYDROLOGY, 2024, 41 : 313 - 321

← 1 2 3 4 5 →